top of page
.png)
in vitro
Influence of a melt derived bioactive glass (F18) over endothelial cells nitric oxide production
J C Oishi et al. Materials Letters: X 3, 100022, 2019.
Histopathological, cytotoxicity and genotoxicity evaluation of Biosilicate glass–ceramic scaffolds.
H W Kido et al. J Biomed Mat Res Part A, 00A, 1-7, 2012
Toxicology and biocompatibility of bioglasses
J Wilson, GH Pigott, FJ Schoen, LL Hench. J Biomed Mater Res. 1981; 15(6):805-17.
Bioceramics: From Concept to Clinic.
L L Hench. Journal of the American Ceramic Society, 1991. 74 (7): p. 1487-1510.
Characterization and biocompatibility of a fibrous glassy scaffold.
P R Gabbai‐Armelin et al. J Tissue Eng Regen Med 11 (4), 1141-1151
The in vitro response of osteoblasts to bioactive glass.
T Matsuda, J E Davies. Biomaterials, 1987. 8(4): p. 275-84.
_edited.png)
Research papers that present our different technologies: F18 & BioS. Also the gold standard Bioglass 45S5.
In vivo
Particulate bioglass compared with hydroxyapatite as a bone graft substitute.
H Oonishi et al. Clin Orthop Relat Res, 1997. 334: p. 316-25.
Evaluation of particulate Bioglass in a rabbit radius ostectomy model.
D L Wheeler et al. J Biomed Mat Res, 1997; 35: p. 249–254.
Effects of biosilicate and bioglass 45S5 on tibial bone consolidation on rats: a biomechanical and a histological study.
R N Granito et al. J Mater Sci Mater Med, 2009. 20(12): p. 2521-6.
Effect of a new bioactive fibrous glassy scaffold on bone repair.
P R Gabbai-Armelin et al. J Mater Sci: Mater Med, 2015; 26: p. 177-29.
Assessment of Resorbable Bioactive Material for Grafting of Critical-size Cancellous Defects.
D L Wheeler et al. J Orthopaedic Research 1999; 18: p. 140-148.
P B F Soares et al. Clinical Oral Implants Research, 2018; 29 (11), 1120-1125.
Research papers that present our different technologies: F18 & BioS. Also the gold standard Bioglass 45S5.
Clinical
Biosilicate®—A multipurpose, highly bioactive glass-ceramic. In vitro, in vivo and clinical trials.
M C Crovace et al. Journal of Non-Crystalline Solids, 2016; 432, 90-110
Clinical Applications of Bioactive Glasses for Maxillo-Facial Repair.
I Thompson in L L Hench et al., New Materials and Technologies for Healthcare, Imperial College Press, London; 2011, 77–96.
Osteoconductive properties and efficacy of resorbable bioactive glass as a bone- grafting material.
T Furusawa, K Mizunuma. Implant Dent., 1997; 6(2):93–101.
How can bioactive glasses be useful in ocular surgery?
F Baino. J Biomed Mater Res Part A, 2014; 103A: 1259–1275.
Clinical Evaluation of Bioactive Glass in the Treatment of Periodontal Osseous Defects in Humans.
T B Lovelace et al. J. Periodontol, 1998; 69 (9), 1027–1035.
E S Tadjoedin et al. Clin Oral Implants Res. 2000; 11(4):334-44.
Bioactive Glass in Sinus Lift Procedures: A Systematic Review.
V Prakash, D Sybil. International Journal of Current Research in Life Sciences, 2018; 7(3), 1320-1323.
C Barrey, T Broussolle. European Journal of Orthopaedic Surgery & Traumatology, 2019; 29:1623–1629.
Research papers that present our different technologies: F18 & BioS. Also the gold standard Bioglass 45S5.
Antibact
Assessment of antimicrobial effect of Biosilicate against anaerobic, microaerophilic and facultative anaerobic microorganisms.
C H G MARTINS, J Mat Sci: Mat Med, 2011; 22 (6), 1439-1446.
Broad-spectrum bactericidal activity of a new bioactive grafting material (F18) against clinically important bacterial strains
M T Souza. International Journal of Antimicrobial Agents, 2017; 50 (6), 730-733.
Bactericidal activity and biofilm inhibition of F18 bioactive glass against Staphylococcus aureus.
T F Passos, M T Souza, E D Zanotto, C W O de Souza. Materials Science and Engineering: C, 2021; 118, 111475.
Biomaterials for orthopedics: anti-biofilm activity of a new bioactive glass coating on titanium implants.
D M Marques. Biofouling, 2020; 36:2, 234-244.
Research papers that present our different technologies: F18 & BioS.
bottom of page